Wells Fargo raised the firm’s price target on Rubrik (RBRK) to $80 from $76 and keeps an Overweight rating on the shares. The firm notes shares ...

The Diamond Hill Long-Short Strategy portfolio trailed the Russell 1000 Index and the blended benchmark. Click here to read ...

Top US banks registered strong comebacks in 2024, exceeding expectations, and they are virtually unanimous that this ...

Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...

Ken Fisher is an American billionaire investment analyst and founder of Fisher Investments, a renowned money management firm ...

William Blair upped their Q2 2025 earnings estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday, March ...

Q4 2024 Earnings Call Transcript March 12, 2025 Tilly’s, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, ...

Nvidia (NVDA) has been at the forefront of the artificial intelligence (AI) revolution, and its annual GPU Technology ...

Burlington, TJX and Ross stand to benefit from tariffs and consumer angst, but one of their most important customer bases is ...

River Road Asset Management reduced its stake in Amgen by 15.7% in Q4, selling 7,606 shares. Several other hedge funds also ...

Daiwa Securities Group Inc. increased its stake in Citigroup by 21.4%, adding 50,363 shares in Q4. The firm now holds 285,471 shares valued at $20.1 million. Other institutional investors also ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on aTyr Pharma (ATYR – Research Report) today and set a price target of $20.00.